PMS38 TOFACITINIB FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATE TO SEVERE ACTIVE PSORIATIC ARTHRITIS INTOLERANT OR WITH THERAPEUTIC FAILURE TO SYNTHETIC OR BIOLOGICAL DISEASE- MODIFYING DRUGS

Página do item simplificado
dc.contributor.authorCosta, MGS
dc.contributor.authorSantos, M
dc.date.accessioned2024-10-29T16:28:17Z
dc.date.available2024-10-29T16:28:17Z
dc.date.issued2020
dc.identifier.citationCosta MGS, Santos M. TOFACITINIB FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATE TO SEVERE ACTIVE PSORIATIC ARTHRITIS INTOLERANT OR WITH THERAPEUTIC FAILURE TO SYNTHETIC OR BIOLOGICAL DISEASE- MODIFYING DRUGS. VALUE IN HEALTH. 2020. doi: 10.1016/j.jval.2020.08.1169
dc.identifier.otherDOI: 10.1016/j.jval.2020.08.1169
dc.identifier.urihttps://dspace.inc.saude.gov.br/handle/123456789/544
dc.language.isoen
dc.publisherVALUE IN HEALTH
dc.titlePMS38 TOFACITINIB FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATE TO SEVERE ACTIVE PSORIATIC ARTHRITIS INTOLERANT OR WITH THERAPEUTIC FAILURE TO SYNTHETIC OR BIOLOGICAL DISEASE- MODIFYING DRUGS
dc.typeArticle
Arquivos
Original bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.alt
Nome:
Costa M et al_Value Health.pdf
Tamanho:
318.09 KB
Formato:
Adobe Portable Document Format
Descrição:
Baixar
License bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.placeholder
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed to upon submission
Descrição:
Baixar
Coleções
Produção Docente